Public Workshop: FDA/FTC Workshop on a Competitive Marketplace for Biosimilars - 03/09/2020 - 03/09/2020

The purpose of the public workshop is to discuss FDA and FTC ’s collaborative efforts to support appropriate adoption of biosimilars, discourage false or misleading statements about biosimilars, and deter anticompetitive behaviors in the biologic marketplace.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news